Correlation Between NewAmsterdam Pharma and Phio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on NewAmsterdam Pharma and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Phio Pharmaceuticals.
Diversification Opportunities for NewAmsterdam Pharma and Phio Pharmaceuticals
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between NewAmsterdam and Phio is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Phio Pharmaceuticals go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Phio Pharmaceuticals
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the Phio Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, NewAmsterdam Pharma is 6.51 times less risky than Phio Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Phio Pharmaceuticals Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 264.00 in Phio Pharmaceuticals Corp on November 27, 2024 and sell it today you would lose (118.50) from holding Phio Pharmaceuticals Corp or give up 44.89% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NewAmsterdam Pharma vs. Phio Pharmaceuticals Corp
Performance |
Timeline |
NewAmsterdam Pharma |
Phio Pharmaceuticals Corp |
NewAmsterdam Pharma and Phio Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NewAmsterdam Pharma and Phio Pharmaceuticals
The main advantage of trading using opposite NewAmsterdam Pharma and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |